J Neurol Surg B Skull Base 2022; 83(06): 594-601
DOI: 10.1055/s-0042-1744452
Review Article

Predictive Factors for Postoperative Opioid Use in Elective Skull Base Craniotomies

Tamia Potter
1   Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
Maria Krywyj
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
Derrick Obiri-Yeboah
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
,
Precious Oyem
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
,
Arbaz Momin
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
,
Kathryn Easley
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
,
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
,
Varun R. Kshettry
2   Department of Neurological Surgery, Rosa Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
3   Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
› Institutsangaben

Abstract

Objective In 2017, the United States officially declared opioid overuse a public health emergency. Due to a paucity of published benchmark data in skull base neurosurgery, we quantified postoperative opioid use in patients undergoing skull base craniotomies and identified factors that influence postoperative opioid use.

Setting Tertiary academic medical center.

Participants Patients who underwent elective craniotomies by two skull base neurosurgeons between January 2015 and May 2020.

Main Outcome Measures Demographic and perioperative data were retrospectively extracted from the electronic medical record. Surgical approaches were categorized as having either “significant” or “minimal” muscle dissection. Univariate and multivariate linear regression analyses were performed to identify predictors of postoperative opioid use at 24, 48, and 72 hours.

Results We included 300 craniotomies, 206 were supratentorial and 94 were infratentorial. This included 195 women and 105 men, with a mean age of 54.9 years. In multivariable analysis, a history of anxiety or depression, preoperative opioid use, and a history of migraines independently predicted a significantly greater opioid use at 24, 48, and 72 hours. Increased age and minimal muscle dissection independently predicted lower opioid consumption. Sex, infratentorial versus supratentorial approach, length of surgery, and postoperative steroid use did not impact total opioid use.

Conclusion Younger age, history of anxiety or depression, preoperative opioid consumption, preexisting history of migraines, and significant intraoperative muscle dissection were associated with higher postoperative opioid consumption. These risk factors provide insight on potential targets for minimizing postoperative opioids in craniotomies.



Publikationsverlauf

Eingereicht: 09. September 2021

Angenommen: 11. Februar 2022

Artikel online veröffentlicht:
27. Juni 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Levy B, Paulozzi L, Mack KA, Jones CM. Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012. Am J Prev Med 2015; 49 (03) 409-413
  • 2 UNODC. World Drug Report. Published 2020. Updated 6/2020. Accessed September 13, 2020 at: https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf
  • 3 Hagemeier NE. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life. Am J Manag Care 2018; 24 (10, Suppl): S200-S206
  • 4 Gottschalk A, Berkow LC, Stevens RD. et al. Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg 2007; 106 (02) 210-216
  • 5 De Benedittis G, Lorenzetti A, Migliore M, Spagnoli D, Tiberio F, Villani RM. Postoperative pain in neurosurgery: a pilot study in brain surgery. Neurosurgery 1996; 38 (03) 466-469 , discussion 469–470
  • 6 Tsaousi GG, Logan SW, Bilotta F. Postoperative pain control following craniotomy: a systematic review of recent clinical literature. Pain Pract 2017; 17 (07) 968-981
  • 7 Thibault M, Girard F, Moumdjian R, Chouinard P, Boudreault D, Ruel M. Craniotomy site influences postoperative pain following neurosurgical procedures: a retrospective study. Can J Anaesth 2007; 54 (07) 544-548
  • 8 Irefin SA, Schubert A, Bloomfield EL, DeBoer GE, Mascha EJ, Ebrahim ZY. The effect of craniotomy location on postoperative pain and nausea. J Anesth 2003; 17 (04) 227-231
  • 9 Vadivelu N, Kai AM, Tran D, Kodumudi G, Legler A, Ayrian E. Options for perioperative pain management in neurosurgery. J Pain Res 2016; 9: 37-47
  • 10 Badash I, Lui CG, Hur K, Acevedo JR, Ference EH, Wrobel BB. Quantifying the use of opioids in the immediate postoperative period after endoscopic sinus surgery. Laryngoscope 2020; 130 (05) 1122-1127
  • 11 Mobini A, Mehra P, Chigurupati R. Postoperative pain and opioid analgesic requirements after orthognathic surgery. J Oral Maxillofac Surg 2018; 76 (11) 2285-2295
  • 12 Stephenson ED, Farzal Z, Jowza M, Hackman T, Zanation A, Du E. Postoperative analgesic requirement and pain perceptions after nonaerodigestive head and neck surgery. Otolaryngol Head Neck Surg 2019; 161 (06) 970-977
  • 13 Sanford Z, Broda A, Taylor H, Turcotte J, Patton CM. Predictive risk factors associated with increased opioid use among patients undergoing elective spine surgery. Int J Spine Surg 2020; 14 (02) 189-194
  • 14 Bernstein JA, Feng J, Mahure SA, Schwarzkopf R, Long WJ. Revision total hip arthroplasty is associated with significantly higher opioid consumption as compared to primary total hip arthroplasty in the acute postoperative period. Hip Int 2020; 30 (1_suppl): 59-63
  • 15 Roof MA, Sullivan CW, Feng JE. et al. Inpatient opioid consumption variability following total knee arthroplasty: analysis of 4,038 procedures. J Knee Surg 2021; 34 (11) 1196-1204
  • 16 Kim SC, Choudhry N, Franklin JM. et al. Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthritis Cartilage 2017; 25 (09) 1399-1406
  • 17 Lavoie-Gagne O, Nwachukwu BU, Allen AA, Leroux T, Lu Y, Forsythe B. Factors predictive of prolonged postoperative narcotic usage following orthopaedic surgery. JBJS Rev 2020; 8 (06) e0154
  • 18 Gill AS, Virani FR, Hwang JC. et al. Preoperative gabapentin administration and its impact on postoperative opioid requirement and pain in sinonasal surgery. Otolaryngol Head Neck Surg 2021; 164 (04) 889-894
  • 19 Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications. Headache 2012; 52 (03) 467-482
  • 20 Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache 2015; 55 (01) 3-20
  • 21 Mayans L, Walling A. Acute migraine headache: treatment strategies. Am Fam Physician 2018; 97 (04) 243-251
  • 22 Ong JJY, De Felice M. Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics 2018; 15 (02) 274-290
  • 23 Dodick DW. Migraine. Lancet 2018; 391 (10127): 1315-1330
  • 24 Bourazani M, Papageorgiou E, Zarkadas G. et al. The role of muscle relaxants – spasmolytic (thiocochlicoside) in postoperative pain management after mastectomy and breast reconstruction. Asian Pac J Cancer Prev 2019; 20 (03) 743-749
  • 25 Perera AP, Chari A, Kostusiak M, Khan AA, Luoma AM, Casey ATH. Intramuscular local anesthetic infiltration at closure for postoperative analgesia in lumbar spine surgery: a systematic review and meta-analysis. Spine 2017; 42 (14) 1088-1095
  • 26 Suffeda A, Meissner W, Rosendahl J, Guntinas-Lichius O. Influence of depression, catastrophizing, anxiety, and resilience on postoperative pain at the first day after otolaryngological surgery: a prospective single center cohort observational study. Medicine (Baltimore) 2016; 95 (28) e4256
  • 27 Goebel S, Baumann B, Steinert A, Reppenhagen S, Faller H. [Elevated postoperative pain levels following orthopedic surgery. Depression as a strong predictor]. Schmerz 2010; 24 (01) 54-61
  • 28 Theunissen M, Peters ML, Bruce J, Gramke HF, Marcus MA. Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain. Clin J Pain 2012; 28 (09) 819-841
  • 29 Dadgostar A, Bigder M, Punjani N, Lozo S, Chahal V, Kavanagh A. Does preoperative depression predict post-operative surgical pain: a systematic review. Int J Surg 2017; 41: 162-173
  • 30 Zeng M, Dong J, Lin N. et al. Preoperative gabapentin administration improves acute postoperative analgesia in patients undergoing craniotomy: a randomized controlled trial. J Neurosurg Anesthesiol 2019; 31 (04) 392-398
  • 31 Shepherd DM, Jahnke H, White WL, Little AS. Randomized, double-blinded, placebo-controlled trial comparing two multimodal opioid-minimizing pain management regimens following transsphenoidal surgery. J Neurosurg 2018; 128 (02) 444-451
  • 32 Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty 2018; 33 (01) 90-96
  • 33 Song J, Li L, Yu P, Gao T, Liu K. Preemptive scalp infiltration with 0.5% ropivacaine and 1% lidocaine reduces postoperative pain after craniotomy. Acta Neurochir (Wien) 2015; 157 (06) 993-998
  • 34 Greenberg S, Murphy GS, Avram MJ. et al. Postoperative intravenous acetaminophen for craniotomy patients: a randomized controlled trial. World Neurosurg 2018; 109: e554-e562
  • 35 Southworth S, Peters J, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther 2009; 31 (09) 1922-1935
  • 36 Galvin IM, Levy R, Day AG, Gilron I. Pharmacological interventions for the prevention of acute postoperative pain in adults following brain surgery. Cochrane Database Syst Rev 2019;2019(11):
  • 37 Song J, Ji Q, Sun Q, Gao T, Liu K, Li L. The opioid-sparing effect of intraoperative dexmedetomidine infusion after craniotomy. J Neurosurg Anesthesiol 2016; 28 (01) 14-20
  • 38 Peng K, Jin XH, Liu SL, Ji FH. Effect of intraoperative dexmedetomidine on post-craniotomy pain. Clin Ther 2015; 37 (05) 1114-1121.e1 , e1111